Clinical Trial Update: Trospium Chloride XR in Obese Female Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on trospium chloride XR in obese women with overactive bladder. The study status is completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Trospium Chloride XR (trospium chloride)

Snippet

Sponsor: Allergan | Conditions: Obesity, Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2013-01-21